Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.

Laura C SahyounJonathan FeteneChandler McMillanPetr ProtivaBadr Al BawardyJill K J GaidosDeborah Proctor

Published in: Digestive diseases and sciences (2024)

Patients with IBD on advanced therapies were frequently treated for acute COVID-19. Although COVID-19 treatment was associated with temporary withholding of IBD therapy, it did not result in increased IBD flares.

Keyphrases

coronavirus disease
sars cov
stem cells
liver failure
ulcerative colitis
respiratory syndrome coronavirus
combination therapy
drug induced
newly diagnosed
aortic dissection